These data suggest that expression of KSHV miR-K12-11 in latent infection normally reduces the level of MYB transcript, and miR-K12-3 behaves similarly against C/EBPα and Ets-1. This evidence concerns the gene CEBPA and disease arising from reactivation of latent virus.